CRT-0044876

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCRT-0044876
Drug Alias NameCRT-0044876
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-(apurinic or apyrimidinic site) lyase inhibitors
TargetsDNA-(apurinic or apyrimidinic site) lyase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research UK
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A